Exact Sciences Corporation (NASDAQ: EXAS) stock closed at $54.72 on 11/6/24 after a major decline of -23.5%. Moreover, trading volume in this decline was exceptionally high at 687% of normal. Relative to the market the stock has been strong over the last nine months but has declined -21.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, EXAS is expected to be a modest Value Builder.
Exact Sciences has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Exact Sciences has a poor Appreciation Score of 25 but a slightly positive Power Rating of 61, triggering the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment